April 11, 2024
In Re: Aflibercept Patent Litigation
Case Number:
1:24-md-03103
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
Chief District Judge Thomas S Kleeh
Firms
- Bowles Rice
- Cravath Swaine
- Fish & Richardson
- Flaherty Sensabaugh
- Gemini Law
- Goodwin Procter
- Hendrickson & Long
- Hissam Forman
- Horn Aylward
- Jenner & Block
- Kellogg Hansen
- Marshall Gerstein
- MoloLamken
- Olson Stein
- Paul Weiss
- Proskauer Rose
- Quinn Emanuel
- Rakoczy Molino
- Robinson Miller
- Rothwell Figg
- Schrader Companion
- Steptoe & Johnson PLLC
- Thomas Combs
- Umhofer Mitchell
- Weil Gotshal
- Wilentz Goldman
- Williams & Connolly
- Willkie Farr
Companies
- Amgen Inc.
- Biocon Ltd.
- Regeneron Pharmaceuticals Inc.
- Samsung Electronics Co. Ltd.
- Sandoz International GmbH
- Viatris Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 12, 2026
Regeneron, Samsung Bioepis Settle Eye Med Patent Claims
Regeneron Pharmaceuticals Inc. and Samsung Bioepis Co. Ltd. have told a West Virginia federal court they reached an agreement to end patent infringement claims brought by Regeneron over a biosimilar of its eye medication Eylea.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login